Curateq Biologics Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 100.00 Cr
as on 16-11-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -85.08%
(FY 2023)
- Profit -76.32%
(FY 2023)
- Ebitda -80.76%
(FY 2023)
- Net Worth -216.31%
(FY 2023)
- Total Assets 21.69%
(FY 2023)
About Curateq Biologics
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 100.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Curateq Biologics Private Limited India are Ankur Pathak as Cfo, Satakarni Makkapati as Ceo, and Pravin Shettigar as Company Secretary. Madan Mettu, Sivakumaran Meenakshisunderam, and Mylandlahalli Ashwini serve as directors at the Company.
- CIN/LLPIN
U24110TG2020PTC140190
- Company No.
140190
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2020
- Date of AGM
19 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Curateq Biologics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ankur Pathak | CFO | 13-Jun-2024 | Current |
| Satakarni Makkapati | CEO | 09-Aug-2021 | Current |
| Pravin Shettigar | Company Secretary | 02-Jul-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madan Mettu  | Director | 25-Apr-2020 | Current |
| Sivakumaran Meenakshisunderam | Director | 25-Apr-2020 | Current |
| Mylandlahalli Ashwini | Director | 13-Jun-2024 | Current |
Financial Performance and Corporate Structure Insights of Curateq Biologics.
Curateq Biologics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 85.08% decrease. The company also saw a substantial fall in profitability, with a 76.32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 216.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curateq Biologics?
In 2023, Curateq Biologics had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Eugia Steriles Private LimitedActive 4 years 5 months
Madan Mettu and Sivakumaran Meenakshisunderam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Curateq Biologics?
Curateq Biologics has a workforce of 424 employees as of Aug 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curateq Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curateq Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
